Complete clinical remission after high-dose immune suppression and autologous hematopoietic stem cell transplantation in severe Crohn's disease refractory to immunosuppresive and immunomodulator therapy [1]

Inflammatory Bowel Diseases

Volumn 10, Issue 6, 2004, Pages 892-894

  Scimè, Rosanna ^a   Cavallaro, Anna Maria ^a   Tringali, Stefania ^a   Santoro, Alessandra ^a   Rizzo, Aroldo ^a   Montalbano, Luigi ^b   Casà, Angelo ^b   Cottone, Mario ^b  

^a VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; AZATHIOPRINE; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; FLUCONAZOLE; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; METRONIDAZOLE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ADULT; ARTHRALGIA; ARTHRITIS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; COLONOSCOPY; CROHN DISEASE; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG DOSE; DRUG RESPONSE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LETTER; MAINTENANCE THERAPY; MALE; MYALGIA; NEUTROPENIA; PRIORITY JOURNAL; REMISSION; STAPHYLOCOCCUS INFECTION; STEM CELL MOBILIZATION; TREATMENT FAILURE; TREATMENT INDICATION;

COMBINED MODALITY THERAPY; CROHN DISEASE; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 9144248465     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200411000-00027     Document Type: Letter

References (5)

1. Burt RK, Traynor A, Oyama Y, et al. High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn's disease. Blood. 2003;101: 2064-2066.
2. Stallmach A, Wittig BM, Moser C, et al. Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid-refractory inflammatory bowel disease. Gut. 2003;52:377-382.
3. Franzke A, Piao W, Lauber J, et al. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood. 2003;102: 734-739.
4. Lopez-Cubera SO, Sullivan KM, McDonald GB. Course of Crohn's disease after allogenic bone marrow transplantation. Gastroenterology 1998; 114:433-440.
5. Sonwalkar SA, James RM, Zhang AL, et al. Fulminant Crohn's colitis after allogenic stem cell transplantation. Gut. 2003;52:1518-1521.